Contrast sparing devices have been slowly adopted into routine patient care. Randomized trial evidence of automated contrast injectors (ACIs) has not been analyzed to evaluate the true reduction in contrast volume during coronary angiography and intervention. It is thought that by reducing the amount of contrast exposure there will be a simultaneous reduction in the risk of CIN. Therefore, we sought to synthesize published evidence on contrast sparing devices, contrast volume and incidence of contrast-induced nephropathy (CIN). We searched Medline, The Cochrane Library, and ClinicalTrials.gov. Search criteria included ACIs compared to manual injection, contrast media volume and incidence of CIN. Data was extracted by two independent reviewers. Weighted mean difference of contrast volume was calculated using random effects models in RevMan 5.4.1 software to derive a summary estimate. A total of 79,694 patients from 10 studies were included (ACI arm n= 20,099; Manual injection arm n= 59,595). On average, ACIs reduced contrast volume delivery by 45 mL per case (p < 0.001, 95%CI: -54, -35). CIN incidence was significantly reduced by 15% with an odds ratio of 0.85 (p<0.001, 95%CI: 0.78, 0.93) for those utilizing ACIs compared to manual injection. In conclusion, ACIs in angiography significantly reduces the volume of contrast delivered to the patient and the incidence of CIN.